Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Microangiopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06182410
What this trial is testing

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Who this might be right for
Transplant-Associated Thrombotic MicroangiopathyNeuroblastomaHigh-risk Neuroblastoma+1 more
University of California, San Francisco
Not applicableStudy completedNCT07732361
What this trial is testing

A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT).

Who this might be right for
Thrombotic MicroangiopathyHematopoietic Stem Cell Transplant
Alexion Pharmaceuticals, Inc. 307
Not applicableLooking for participantsNCT07347990
What this trial is testing

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyHematopoietic Stem Cell Transplantation (HSCT)
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459114
What this trial is testing

TGD001 Treatment in Thrombotic Microangiopathies

Who this might be right for
Thrombotic MicroangiopathiesITP Immune-Mediated Thrombocytopenia
TargED Biopharmaceuticals B.V. 70
Not applicableEnded earlyNCT01742156
What this trial is testing

Single Blind Randomized Study to Determine the Sensitivity and Specificity of 2 Non-invasive Markers of Early Coronary Disease

Who this might be right for
Coronary Artery Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 10
Testing effectiveness (Phase 2)Study completedNCT03518203
What this trial is testing

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Thrombotic MicroangiopathiesAtypical Hemolytic Uremic SyndromeMultiple Organ Dysfunction Syndrome
Children's Hospital Medical Center, Cincinnati 23
Large-scale testing (Phase 3)Study completedNCT03252925
What this trial is testing

A Safety and Efficacy Study of NAC in Patients With TA-TMA

Who this might be right for
Thrombotic MicroangiopathiesHematologic Diseases
The First Affiliated Hospital of Soochow University 170
Not applicableUnknownNCT04845022
What this trial is testing

Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome

Who this might be right for
SNAKEBITETHROMBOTIC MICROANGIOPATHYSCHISTOCYTES
Jubilee Mission Medical College and Research Institute 81
Post-approval studies (Phase 4)Looking for participantsNCT05743400
What this trial is testing

Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
Hospices Civils de Lyon 35
Large-scale testing (Phase 3)Study completedNCT04543591
What this trial is testing

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

Who this might be right for
Thrombotic Microangiopathy
Alexion Pharmaceuticals, Inc. 148
Testing effectiveness (Phase 2)Ended earlyNCT02763644
What this trial is testing

Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients

Who this might be right for
Transplant Associated Microangiopathy TAM
Novartis Pharmaceuticals 7
Not applicableUnknownNCT03594591
What this trial is testing

Changes in the Retinal and Carotid Microcirculation After Restoring Normoglycemia in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusMicroangiopathyDiabetic Retinopathy+2 more
Hospital Clinic of Barcelona 20
Not applicableLooking for participantsNCT01522183
What this trial is testing

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 3,000
Not applicableUnknownNCT02248311
What this trial is testing

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population

Who this might be right for
Type2 Diabetes MellitusMicroangiopathyNon Alcoholic Fatty Liver Disease+4 more
Hospital Universitari Vall d'Hebron Research Institute 260
Not applicableStudy completedNCT03246542
What this trial is testing

Promising Bimarker Prediction of Outcome of HELLP Syndrome.

Who this might be right for
Pre-Eclampsia, SevereHELLP SyndromeMicroangiopathy
AYMAN ABDELKADER MOHAMED ABDELKADER 100
Large-scale testing (Phase 3)Study completedNCT04889430
What this trial is testing

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 34
Not applicableActive Not RecruitingNCT01411033
What this trial is testing

Poznan Prospective Study of Type 1 Diabetic Patients

Who this might be right for
MicroangiopathyMacroangiopathyInsulin Treatment Overcorrection+1 more
Poznan University of Medical Sciences 100
Not applicableLooking for participantsNCT07059026
What this trial is testing

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Who this might be right for
Thrombotic Microangiopathy
ITAC (Instituto de Trasplantes y Alta Complejidad) 200
Large-scale testing (Phase 3)Ended earlyNCT04743804
What this trial is testing

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Who this might be right for
Thrombotic Microangiopathy
Alexion Pharmaceuticals, Inc. 16
Large-scale testing (Phase 3)Active Not RecruitingNCT07279610
What this trial is testing

N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic Microangiopathy
The First Affiliated Hospital of Soochow University 44
Next Page